Illumina Countersues Life Technologies in Ongoing Sequencing Patent Row

Illumina and Solexa denied all of Life's and ABI's allegations of patent infringement; asserted that ABI's licensed patents are invalid; and countersued Life and ABI for allegedly infringing four Solexa patents with their SOLiD sequencing system.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.